The author would like to correct the errors in the publication of the original article. The corrected details are given below for your reading.
Firstly, on page 1, in the abstract paragraph under the heading results, ''and Q max (p B 0.05)'' has to be removed and the revised text should read as ''Silodosin was more effective than tamsulosin 0.2 mg with regard to some IPSS-related parameters.'' Secondly, on page 6, 2nd paragraph under the heading ''Silodosin versus tamsulosin,'' the text is amended with few changes and the revised text should read as ''Silodosin was more effective than tamsulosin 0.2 mg with regard to mean change in IPSS voiding subscore (WMD: -0.75; p = 0.03) (Fig. 2c) , and IPSS quality-oflife item (WMD: -0.26; p = 0.02) (Fig. 2d) . Conversely, only a non-statistically significant trend in favor of silodosin when compared with tamsulosin 0.2 mg was found with regard to mean change in IPSS total score (WMD: -1.48; p = 0.08) (Fig. 2a) and IPSS storage subscore (WMD: -0.31; p = 0.14) (Fig. 2b) . Silodosin and tamsulosin 0.4 mg were at least as effective in all the efficacy analyses ( Fig. 2a-e) .'' Finally, on page 10, last sentence of the 1st paragraph should read as ''However, post hoc analyses of the European registrational trial found a significant difference in favor of silodosin in comparison with tamsulosin 0.4 for 3 IPSS symptoms (incomplete emptying, frequency, nocturia) considered simultaneously in patients with either moderate or severe LUTS [24] .''
